<unk>  <unk> , brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV.<unk>  is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to<unk> .<unk>  is marketed by Janssen, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for patients with established resistance to other drugs, making it the 30th anti-HIV drug approved in the United States and the first to be approved in 2008. It was also approved for use in Canada on April 1, 2008.<unk>  is licensed in the United States, Canada, Israel, Russia, Australia and the European Union, and is under regulatory review in Switzerland.
Etravirine
Elbasvir
Telbivudine
Lamivudine
Sorivudine
Nevirapine
Saquinavir
Maribavir